Macrogenics (MGNX) Change in Accured Expenses (2012 - 2026)

Macrogenics (MGNX) has reported Change in Accured Expenses for 15 consecutive years, with -$3.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Accured Expenses fell 397.04% year-over-year to -$3.7 million; the TTM figure through Mar 2026 stood at -$11.8 million (down 668.64% YoY), while the FY2025 annual figure was -$6.8 million, down 236.6% from the prior year.
• Change in Accured Expenses grew to -$3.7 million in Q1 2026 per MGNX's latest filing, from -$7.8 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $8.6 million in Q3 2025 and bottomed at -$11.9 million in Q1 2022.
• Historically, Change in Accured Expenses has averaged -$599294.1 across 5 years, with a median of -$427000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses plunged 1494.15% — and 2025, when it soared 4229.29%.
• Macrogenics' Change in Accured Expenses stood at $6.3 million in 2022, then sank by 74.32% to $1.6 million in 2023, then jumped by 171.0% to $4.4 million in 2024, then slumped by 278.07% to -$7.8 million in 2025, then surged by 52.04% to -$3.7 million in 2026.
• Business Quant data shows MGNX's Change in Accured Expenses at -$3.7 million in Q1 2026, -$7.8 million in Q4 2025, and $8.6 million in Q3 2025.